Bone Metastases in Lung Cancer: An Introduction

Article

I've discussed the general management of metastatic lung cancer, both SCLC and NSCLC, but there are also several common complications that sometimes require particular management. Bone metastases, for instance, may be treated by the same "whole body" approach with chemotherapy that treats other areas of tumor involvement, but may also benefit from additional approaches.

PET Scans For Restaging After Induction Treatment for Stage IIIA NSCLC

Article

Purists have considered mediastinoscopy, which is invasive staging of the mediastinum through a small incision just at the base of the neck to get down behind the sternum, or breastbone, to be the "gold standard" for determining whether lymph nodes in the mediastinum, or middle of the chest, is involved with a cancer. The procedure is as shown:

The Future of the Field: "Molecular Epidemiology" and SWOG Trial 0424

Article

It's only been in the past few years that we have begun to appreciate that there may be many different subgroups of patients who fit within the broader lung cancer population. We now have begun to see differences in the safety and/or activity of certain drugs in never-smokers vs. smokers, patients with adenocarcinomas (and especially bronchioloalveolar carcinoma, or BAC)vs. squamous cell carcinomas or other subtypes, and even in women compared with men.